Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Vermersch

Showing results (61-70 of 219) with videos related to

Pageof 22
Sort By:
Revue Neurologique|February 1, 1995
[Strongyloides stercoralis myelitis]H Hénon, P Vermersch, E Dutoit, et al.
Neuroscience Letters|September 14, 1992
Presence of abnormally phosphorylated Tau proteins in the entorhinal cortex of aged non-demented subjectsP Vermersch, B Frigard, J P David, et al.
Revue Neurologique|January 1, 1992
[Stiff-Man syndrome with late onset]P Vermersch, J F Hurtevent, F Pasquier, et al.
Annals of Neurology|May 11, 2000
Effect of glatiramer acetate (Copaxone) given orally in human patients: interleukin-10 production during a phase 1 trialJ de Seze, G Edan, M Labalette, et al.
Acta Neurologica Scandinavica|October 22, 2016
JCV serology in time: 3 years of follow-upM Cambron, N Hadhoum, E Duhin, et al.
Revue Neurologique|January 1, 1990
[Fulminating cryptococcal meningoencephalitis. An anatomo-clinical case]P Vermersch, D Leys, M Lorthioir, et al.
Revue Neurologique|March 12, 2002
[Tubular aggregate congenital myopathy associated with neuromuscular block]H Zephir, T Stojkovic, C A Maurage, et al.
Revue Neurologique|April 27, 2002
[Chronic polyradiculoneuritis disclosing sarcoidosis]D Ferriby, T Stojkovic, J De Seze, et al.
Annals of Neurology|May 1, 1993
Dementia in Parkinson's disease: biochemical evidence for cortical involvement using the immunodetection of abnormal Tau proteinsP Vermersch, A Delacourte, F Javoy-Agid, et al.
Lancet (London, England)|September 30, 1989
Severe oedema after subcutaneous apomorphine in Parkinson's diseaseP Vermersch, F Mounier-Vehier, J Caron, et al.
Pageof 22

Showing results (61-70 of 219) with videos related to

Sort By:
Pageof 22
Revue Neurologique|February 1, 1995
[Strongyloides stercoralis myelitis]H Hénon, P Vermersch, E Dutoit, et al.
Neuroscience Letters|September 14, 1992
Presence of abnormally phosphorylated Tau proteins in the entorhinal cortex of aged non-demented subjectsP Vermersch, B Frigard, J P David, et al.
Revue Neurologique|January 1, 1992
[Stiff-Man syndrome with late onset]P Vermersch, J F Hurtevent, F Pasquier, et al.
Annals of Neurology|May 11, 2000
Effect of glatiramer acetate (Copaxone) given orally in human patients: interleukin-10 production during a phase 1 trialJ de Seze, G Edan, M Labalette, et al.
Acta Neurologica Scandinavica|October 22, 2016
JCV serology in time: 3 years of follow-upM Cambron, N Hadhoum, E Duhin, et al.
Revue Neurologique|January 1, 1990
[Fulminating cryptococcal meningoencephalitis. An anatomo-clinical case]P Vermersch, D Leys, M Lorthioir, et al.
Revue Neurologique|March 12, 2002
[Tubular aggregate congenital myopathy associated with neuromuscular block]H Zephir, T Stojkovic, C A Maurage, et al.
Revue Neurologique|April 27, 2002
[Chronic polyradiculoneuritis disclosing sarcoidosis]D Ferriby, T Stojkovic, J De Seze, et al.
Annals of Neurology|May 1, 1993
Dementia in Parkinson's disease: biochemical evidence for cortical involvement using the immunodetection of abnormal Tau proteinsP Vermersch, A Delacourte, F Javoy-Agid, et al.
Lancet (London, England)|September 30, 1989
Severe oedema after subcutaneous apomorphine in Parkinson's diseaseP Vermersch, F Mounier-Vehier, J Caron, et al.
Pageof 22